Explore All Access
Check if your research matches the topics covered in ALTEX: Alternatives to Animal Experimentation?
- Degree of match
- Common matching concepts
- Additional journal recommendations
ALTEX: Alternatives to Animal Experimentation : Impact Factor & More
eISSN: 1868-596X
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
ALTEX: Alternatives to Animal Experimentation Key Metrics
Impact Factor 
5 - 10
ALTEX: Alternatives to Animal Experimentation Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Springer Spektrum |
| Language | English |
| Article Processing Charges | EUR 2000 |
| Publication Time | 18 |
| Editorial Review Process | Blind peer review,Double blind peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Blind peer review,Double blind peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in ALTEX: Alternatives to Animal Experimentation ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in ALTEX: Alternatives to Animal Experimentation
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl1
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl8
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl7
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_suppl2
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl6
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl5
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl1
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl8
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl7
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_suppl2
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl6
- 1 Jan 2024
- ALTEX
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl5
- 1 Jan 2024
- ALTEX
FAQs on ALTEX: Alternatives to Animal Experimentation
How many articles did ALTEX: Alternatives to Animal Experimentation publish last year? 
In 2023, ALTEX: Alternatives to Animal Experimentation publsihed 41 articles.
Who is the publisher of ALTEX: Alternatives to Animal Experimentation?
Springer Spektrum is the publisher of ALTEX: Alternatives to Animal Experimentation.